Asunra 400mg Tablet 6'S

Poisoning/Overdose Rx required

Best Price*  ₹ 661.60
MRP ₹827.00
(Inclusive of all taxes) *6 Tablet(s) in a Strip * Mkt: Novartis Healthcare Pvt Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout

Check Availability & Expiry

PINCODE:


INTRODUCTION

ASUNRA 400MG contains Deferasirox which belongs to the group of medicines called iron chelator. It is used to treat chronic iron overload caused by frequent blood transfusions in patients (aged 6 years or above) with beta thalassaemia major. It is also used to treat chronic iron overload caused by infrequent blood transfusion in patients with other types of anemia, and in children aged 2-5 years. It can also correct iron overload in patients aged 10 years or older who have thalassaemia syndromes, but who are not transfusion dependent.

ASUNRA 400MG traps and removes the excess iron from the body and excretes them mainly in the stools. During the course of treatment, your doctor may recommend you have regular blood and urine tests to monitor the amount of iron in your body. Regular monitoring of your kidney and liver functions is also necessary, as they may reduce the risks of unwanted side effects. The most common side effect of taking this medicine are nausea, vomiting, abdominal pain, constipation, diarrhea, bloating or signs of liver and kidney damage. Talk to your doctor if any of these symptom bothers you.

Take this medicine as directed by your physician. It can be taken once daily. However, your doctor will decide the correct dose, duration and time of consumption depending upon your age, weight and health condition. Do not take this medicine if you are pregnant or breastfeeding or having advanced myelodysplastic syndrome or advanced cancer. Consult your doctor before taking. Before taking this medicine inform your doctor if you have any liver, kidney or heart disease. This medicine is not recommended for use in children aged below 2 years. Consult your doctor before taking this medicine.

USES OF ASUNRA 400MG

  • Treats chronic iron overload due to frequent blood transfusions in patients (aged 6 years or above) with beta thalassaemia major
  • Treats chronic iron overload due to infrequent blood transfusion in patients (2 years or above) with other types of anemia
  • Treats iron overload in patients (aged 10 years or older) with non-transfusion dependent thalassaemia syndrome

HOW ASUNRA 400MG WORKS

ASUNRA 400MG is an iron chelator which traps and removes the excess iron from your body. It specifically binds to iron (ferric form) at the ratio of 2:1, forming a stable complex (iron chelate), which is excreted mainly in the stools.

DIRECTIONS FOR USE

Take ASUNRA 400MG as directed by your physician. It can be taken once daily. However, your doctor will decide the correct dose, duration and time of consumption depending upon your age, weight and health condition. Swallow the medicine as whole with a sip of water. Continue to take this medicine, as long as your doctor tells you to do so, to obtain better results.

SIDE EFFECTS OF ASUNRA 400MG

SERIOUS

  • allergic reaction (such as severe rash, swelling of the face and throat, difficulty in breathing and dizziness)
  • severe skin reactions (such as skin rash, red skin, blistering of lips, eyes or mouth, skin peeling, high fever, flu-like symptoms and enlarged lymph nodes)
  • kidney problem (decreased urine output)
  • liver problem (such as drowsiness, upper right abdominal pain, yellowing of skin or eyes and dark urine)
  • high ammonia levels in blood (such as difficulty in thinking, remembering information, or solving problems, being less alert, feeling sleepy with low energy)
  • vomiting blood
  • black stools
  • frequent heartburn
  • blurred vision
  • pancreatitis (severe pain in upper stomach)

COMMON

  • GI disorders (such as nausea, vomiting, diarrhea, abdominal pain, bloating, constipation or indigestion)
  • skin rash
  • headache
  • itching
  • disturbance in kidney or liver function tests

HOW TO MANAGE SIDE EFFECTS

Nausea or vomiting:

Try taking this medicine with, or just after meals. Stick to simple meals. Do not eat rich or spicy food.

Bloating or wind:

Eat smaller and frequent meals. Eat and drink slowly, and exercise regularly. If the symptoms get worse, contact your doctor immediately.

Constipation: 

Eat fibre rich foods like fresh fruit, vegetables and cereals. Drink plenty of water. Exercise more regularly.

Diarrhea:

Drink lots of fluids, such as water or juice, to avoid dehydration. Do not take any medicines without speaking to a doctor.

Abdominal pain:

Try to rest and relax. You can eat and drink slowly or have smaller and frequent meals. Keeping a heat pad on your stomach may also help. If still pain persists, speak to your doctor.

Dark or black stools:

This is common while taking this medicine and is nothing to worry about. Talk to a doctor if your poo is black and sticky or if you also feel unwell in any other way.

Skin rash or itching:

Avoid hot showers because hot water can irritate the skin. Do not rub or scratch the affected area. Use sunscreen and protective clothing when outdoors. Regularly use moisturizers to soothe and hydrate the affected area. If it does not get better, speak to a doctor.

WARNING & PRECAUTIONS

PREGNANCY

ASUNRA 400MG is not recommended for use in pregnant women unless clearly necessary. Consult your doctor for advice.

BREASTFEEDING

ASUNRA 400MG is not recommended for use in breastfeeding women unless clearly necessary. Consult your doctor for advice.

DRIVING AND USING MACHINES

Do not drive or operate any machines if your ability is affected by this medicine.

ALCOHOL

Avoid consumption of alcohol while taking this medicine.

KIDNEY

ASUNRA 400MG is not recommended for use in patients with moderate or severe kidney disease. Consult your doctor for advice.

LIVER

ASUNRA 400MG should be taken with caution in patients with liver disease. Consult your doctor for advice.

ALLERGY

Do not take this medicine if you are allergic (hypersensitive) to deferasirox or any other ingredients in this medicine.

HEART DISEASE

ASUNRA 400MG should be taken with caution in patients with cardiac problem due to iron-overload. Consult your doctor for advice.

OTHERS

Do not take this medicine, if you have:

  • advanced myelodysplastic syndrome (decreased production of blood cells by bone marrow) or advanced cancer

INTERACTIONS

Talk to your doctor, if you are taking,

  • other iron chelator medicines (e.g. desferrioxamine)
  • antacids (used to treat heartburn) containing aluminium e.g. Aluminium hydroxide
  • ciclosporin (used to prevent graft rejection, rheumatoid arthritis or atopic dermatitis)
  • simvastatin and cholestyramine (used to reduce high cholesterol levels in blood)
  • medicines used to treat pain and inflammation (e.g. aspirin, ibuprofen, corticosteroids)
  • medicines used to prevent or treat blood clotting (e.g. heparin, warfarin)
  • medicines used to treat epilepsy (e.g. phenytoin, phenobarbital, carbamazepine)
  • oral bisphosphonates (used to treat osteoporosis) e.g. alendronate, etidronate, risedronate and zoledronic acid
  • contraceptive agents (birth control pills)
  • bepridil (used to treat heart problems)
  • ergotamine (used to treat migraines)
  • repaglinide (used to treat diabetes)
  • rifampicin (used to treat tuberculosis)
  • ritonavir (used to treat HIV infection)
  • paclitaxel (used to treat cancer)
  • theophylline (used to treat as asthma)
  • clozapine (used to treat psychiatric disorders)
  • tizanidine (used as a muscle relaxant)
  • busulfan (used to treat a certain type of chronic myelogenous leukemia)

SYNOPSIS

Drug :   Deferasirox
Pharmacological Category :   Iron chelator
Therapeutic Indication :   Chronic iron-overload
Dosage Forms :   Tablet

MORE INFORMATION

Store at room temperature and keep out of reach of children.

FAQs ABOUT ASUNRA 400MG

What are the uses of ASUNRA 400MG?

It is used to treat iron-overload in patients with transfusion-dependent or non-transfusion dependent beta thalassaemia or other types of anemia.

Can ASUNRA 400MG be taken by children?

Yes. This medicine is suitable for use in children aged above 2 years. However, consult your doctor before taking.

Can ASUNRA 400MG be crushed?

Try to swallow this medicine as whole with a sip of water. For patients who are unable to swallow as whole, crush this medicine and sprinkle it onto soft food such as yogurt or apple sauce and consume it immediately.

Can ASUNRA 400MG cause liver damage?

Yes. This medicine may rarely cause liver damage in some individuals. Contact your doctor immediately if you are experiencing any signs of liver damage such as drowsiness, upper right abdominal pain, yellowing of skin or eyes and dark urine after taking this medicine.

REFERENCES

1. Michael C. Byrns and Trevor M. Penning. Environmental toxicology: carcinogens and heavy metals. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1876.

2. Gerald G. Briggs and Roger K. Freeman. D. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 1056-1057.

3. Novartis Pharmaceuticals. A Study Assessing the Efficacy and Safety of Deferasirox in Patients with Transfusion-dependent Iron Overload. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on February 2020] [Accessed 28th November 2020] https://clinicaltrials.gov/ct2/show/NCT00171821

4. Novartis Pharmaceuticals. Efficacy and Safety Study of Deferasirox in Patients with Non-transfusion Dependent Thalassemia (THETIS). NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on October 2019] [Accessed 28th November 2020] https://www.clinicaltrials.gov/ct2/show/NCT01709838

5. Ali Taher, Amal El-Beshlawy, Mohsen S Elalfy, Kusai Al Zir, Shahina Daar, Dany Habr, Ulrike Kriemler-Krahn, Abdel Hmissi and Abdullah Al Jefri. Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study. NCBI; PMC US National Library of Medicine, National Institute of Health. June 2009. [Accessed 28th November 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730551/

6. Taj Pharma India Ltd. DEFRATAJ 500MG, 250MG (DEFERASIROX). [Accessed 28th November 2020] https://defrataj.tajpharma.com/patient-information-leaflet-defrataj-film-coated-tablets.pdf

7. Ciplamed. DESIROX Tablets (Deferasirox). Ciplamed.com. [Revised on April 2020] [Accessed 28th November 2020] https://www.ciplamed.com/content/desirox-tablets

8. Novartis Pharma GmbH. Electronic Medicines Compendium (EMC); [Revised on July 2019] [Accessed 28th November 2020] https://www.medicines.org.uk/emc/files/pil.4329.pdf

9. Novartis Pharma Stein AG. U.S. Food & Drug Administration; [Revised on April 2007] [Accessed 28th November 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021882s002lbl.pdf

USEFUL DIAGNOSTIC TESTS

  • Iron Serum
  • Iron Studies
  • Total Iron Binding Capacity

PRODUCT DETAILS

    Net Qty
    1
    Ingredient
    DEFERASIROX 400MG
    Hsn Code
    30049099
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Asunra 400mg Tablet 6'S

Asunra 400mg Tablet 6'S Mkt: Novartis Healthcare Pvt Ltd

M.R.P.: Rs.827.00
Copyright© 2021. All Rights Reserved.